Streetbeat News

Stock Prices

T

AT&T (T) reported solid 2Q results with revenue of $29.9 billion, up 0.9% Y/Y, and EBITDA of $11.1 billion, beating estimates. The company hit its $6 billion run rate of annual savings ahead of schedule and plans to add an incremental $2 billion in the next three years. Analysts from Raymond James, Oppenheimer, and Goldman Sachs provided their ratings and price targets, with Raymond James reiterating a Strong Buy with a price target of $25, Oppenheimer maintaining a Perform rating, and Goldman Sachs maintaining a Buy but lowering the price target from $23 to $20.

Portfolio Pulse from Anusuya Lahiri

July 27, 2023 | 6:04 pm

CDE

EGO

EXK

GFI

HL

HMY

MUX

Shares of precious metals stocks are trading lower due to a rise in the US dollar. The stocks mentioned include CDE, EGO, EXK, GFI, HL, HMY, MUX.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 6:03 pm

CNI

Over the past 3 months, 7 analysts have published indifferent opinions on Canadian National Railway (NYSE:CNI) stock. The company has an average price target of $130.71, representing a 3.28% decrease from the previous average price target of $135.14.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:01 pm

MAA

Over the past 3 months, 5 analysts have published their opinion on Mid-America Apartment (NYSE:MAA) stock. The average price target is $168.2, implying an upside from the current price of $148.82. However, this average has decreased by 4.25% from the previous average price target of $175.67.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:01 pm

OTIS

Over the past 3 months, 6 analysts have published indifferent opinions on Otis Worldwide (NYSE:OTIS) stock. The average 12-month price target for the stock is $87.67, an increase of 4.37% from the previous average price target of $84.00.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:01 pm

SCCO

Southern Copper's (NYSE:SCCO) short percent of float has risen 4.58% since its last report, with 5.45 million shares sold short, which is 6.4% of all regular shares available for trading. It would take traders 5.6 days to cover their short positions on average. The company's short interest is higher than most of its peers, with an average of 3.82%.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:00 pm

MRNA

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years, producing an average annual return of 45.09%. If an investor had bought $1000 of MRNA stock 5 years ago, it would be worth $6,429.45 today.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:00 pm

NUE

Nucor (NYSE:NUE) has received mixed analyst ratings in the last quarter, with 2 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target for Nucor, according to 7 analysts, is $160.86, which has increased by 7.78% over the past month.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:00 pm

ITUB

Itau Unibanco Holding's (NYSE:ITUB) short percent of float has fallen 3.85% since its last report, with 23.98 million shares sold short, which is 0.5% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, Itau Unibanco has less short interest as a percentage of float.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:00 pm

CDW

CDW (NASDAQ:CDW) has outperformed the market over the past 10 years by 13.83% on an annualized basis, producing an average annual return of 24.29%. If an investor had bought $100 of CDW stock 10 years ago, it would be worth $875.69 today.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 6:00 pm